A Protocol for Fabrication and on-Chip Cell Culture to Recreate PAH-Afflicted Pulmonary Artery on a Microfluidic Device

Pulmonary arterial hypertension (PAH) is a rare pulmonary vascular disease that affects people of all ethnic origins and age groups including newborns. In PAH, pulmonary arteries and arterioles undergo a series of pathological changes including remodeling of the entire pulmonary vasculatures and ext...

Full description

Bibliographic Details
Main Authors: Tanoy Sarkar, Trieu Nguyen, Sakib M. Moinuddin, Kurt R. Stenmark, Eva S. Nozik, Dipongkor Saha, Fakhrul Ahsan
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Micromachines
Subjects:
Online Access:https://www.mdpi.com/2072-666X/13/9/1483
_version_ 1797484673872429056
author Tanoy Sarkar
Trieu Nguyen
Sakib M. Moinuddin
Kurt R. Stenmark
Eva S. Nozik
Dipongkor Saha
Fakhrul Ahsan
author_facet Tanoy Sarkar
Trieu Nguyen
Sakib M. Moinuddin
Kurt R. Stenmark
Eva S. Nozik
Dipongkor Saha
Fakhrul Ahsan
author_sort Tanoy Sarkar
collection DOAJ
description Pulmonary arterial hypertension (PAH) is a rare pulmonary vascular disease that affects people of all ethnic origins and age groups including newborns. In PAH, pulmonary arteries and arterioles undergo a series of pathological changes including remodeling of the entire pulmonary vasculatures and extracellular matrices, mis-localized growth of pulmonary arterial cells, and development of glomeruloid-like lesions called plexiform lesions. Traditionally, various animal and cellular models have been used to understand PAH pathophysiology, investigate sex-disparity in PAH and monitor therapeutic efficacy of PAH medications. However, traditional models can only partially capture various pathological features of PAH, and they are not adaptable to combinatorial study design for deciphering intricately intertwined complex cellular processes implicated in PAH pathogenesis. While many microfluidic chip-based models are currently available for major diseases, no such disease-on-a-device model is available for PAH, an under investigated disease. In the absence of any chip-based models of PAH, we recently proposed a five-channel polydimethylsiloxane (PDMS)-based microfluidic device that can emulate major pathological features of PAH. However, our proposed model can make a bigger impact on the PAH field only when the larger scientific community engaged in PAH research can fabricate the device and develop the model in their laboratory settings. With this goal in mind, in this study, we have described the detailed methodologies for fabrication and development of the PAH chip model including a thorough explanation of scientific principles for various steps for chip fabrication, a detailed list of reagents, tools and equipment along with their source and catalogue numbers, description of laboratory setup, and cautionary notes. Finally, we explained the methodologies for on-chip cell seeding and application of this model for studying PAH pathophysiology. We believe investigators with little or no training in microfluidic chip fabrication can fabricate this eminently novel PAH-on-a-chip model. As such, this study will have a far-reaching impact on understanding PAH pathophysiology, unravelling the biological mystery associated with sexual dimorphism in PAH, and developing PAH therapy based on patient sex and age.
first_indexed 2024-03-09T23:07:47Z
format Article
id doaj.art-5dc2652a417541969834944a14a2944a
institution Directory Open Access Journal
issn 2072-666X
language English
last_indexed 2024-03-09T23:07:47Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Micromachines
spelling doaj.art-5dc2652a417541969834944a14a2944a2023-11-23T17:50:16ZengMDPI AGMicromachines2072-666X2022-09-01139148310.3390/mi13091483A Protocol for Fabrication and on-Chip Cell Culture to Recreate PAH-Afflicted Pulmonary Artery on a Microfluidic DeviceTanoy Sarkar0Trieu Nguyen1Sakib M. Moinuddin2Kurt R. Stenmark3Eva S. Nozik4Dipongkor Saha5Fakhrul Ahsan6Department of Pharmaceutical and Biomedical Sciences, California Northstate University College of Pharmacy, Elk Grove, CA 95757, USADepartment of Pharmaceutical and Biomedical Sciences, California Northstate University College of Pharmacy, Elk Grove, CA 95757, USADepartment of Pharmaceutical and Biomedical Sciences, California Northstate University College of Pharmacy, Elk Grove, CA 95757, USADepartment of Pediatrics and Medicine, Cardiovascular Pulmonary Research Laboratories, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, USADepartment of Pediatrics and Medicine, Cardiovascular Pulmonary Research Laboratories, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045, USADepartment of Pharmaceutical and Biomedical Sciences, California Northstate University College of Pharmacy, Elk Grove, CA 95757, USADepartment of Pharmaceutical and Biomedical Sciences, California Northstate University College of Pharmacy, Elk Grove, CA 95757, USAPulmonary arterial hypertension (PAH) is a rare pulmonary vascular disease that affects people of all ethnic origins and age groups including newborns. In PAH, pulmonary arteries and arterioles undergo a series of pathological changes including remodeling of the entire pulmonary vasculatures and extracellular matrices, mis-localized growth of pulmonary arterial cells, and development of glomeruloid-like lesions called plexiform lesions. Traditionally, various animal and cellular models have been used to understand PAH pathophysiology, investigate sex-disparity in PAH and monitor therapeutic efficacy of PAH medications. However, traditional models can only partially capture various pathological features of PAH, and they are not adaptable to combinatorial study design for deciphering intricately intertwined complex cellular processes implicated in PAH pathogenesis. While many microfluidic chip-based models are currently available for major diseases, no such disease-on-a-device model is available for PAH, an under investigated disease. In the absence of any chip-based models of PAH, we recently proposed a five-channel polydimethylsiloxane (PDMS)-based microfluidic device that can emulate major pathological features of PAH. However, our proposed model can make a bigger impact on the PAH field only when the larger scientific community engaged in PAH research can fabricate the device and develop the model in their laboratory settings. With this goal in mind, in this study, we have described the detailed methodologies for fabrication and development of the PAH chip model including a thorough explanation of scientific principles for various steps for chip fabrication, a detailed list of reagents, tools and equipment along with their source and catalogue numbers, description of laboratory setup, and cautionary notes. Finally, we explained the methodologies for on-chip cell seeding and application of this model for studying PAH pathophysiology. We believe investigators with little or no training in microfluidic chip fabrication can fabricate this eminently novel PAH-on-a-chip model. As such, this study will have a far-reaching impact on understanding PAH pathophysiology, unravelling the biological mystery associated with sexual dimorphism in PAH, and developing PAH therapy based on patient sex and age.https://www.mdpi.com/2072-666X/13/9/1483chip fabricationPDMS-based chipPAH-on-a-chipPAH-chippulmonary arterial hypertensionpulmonary arterial cells on chip
spellingShingle Tanoy Sarkar
Trieu Nguyen
Sakib M. Moinuddin
Kurt R. Stenmark
Eva S. Nozik
Dipongkor Saha
Fakhrul Ahsan
A Protocol for Fabrication and on-Chip Cell Culture to Recreate PAH-Afflicted Pulmonary Artery on a Microfluidic Device
Micromachines
chip fabrication
PDMS-based chip
PAH-on-a-chip
PAH-chip
pulmonary arterial hypertension
pulmonary arterial cells on chip
title A Protocol for Fabrication and on-Chip Cell Culture to Recreate PAH-Afflicted Pulmonary Artery on a Microfluidic Device
title_full A Protocol for Fabrication and on-Chip Cell Culture to Recreate PAH-Afflicted Pulmonary Artery on a Microfluidic Device
title_fullStr A Protocol for Fabrication and on-Chip Cell Culture to Recreate PAH-Afflicted Pulmonary Artery on a Microfluidic Device
title_full_unstemmed A Protocol for Fabrication and on-Chip Cell Culture to Recreate PAH-Afflicted Pulmonary Artery on a Microfluidic Device
title_short A Protocol for Fabrication and on-Chip Cell Culture to Recreate PAH-Afflicted Pulmonary Artery on a Microfluidic Device
title_sort protocol for fabrication and on chip cell culture to recreate pah afflicted pulmonary artery on a microfluidic device
topic chip fabrication
PDMS-based chip
PAH-on-a-chip
PAH-chip
pulmonary arterial hypertension
pulmonary arterial cells on chip
url https://www.mdpi.com/2072-666X/13/9/1483
work_keys_str_mv AT tanoysarkar aprotocolforfabricationandonchipcellculturetorecreatepahafflictedpulmonaryarteryonamicrofluidicdevice
AT trieunguyen aprotocolforfabricationandonchipcellculturetorecreatepahafflictedpulmonaryarteryonamicrofluidicdevice
AT sakibmmoinuddin aprotocolforfabricationandonchipcellculturetorecreatepahafflictedpulmonaryarteryonamicrofluidicdevice
AT kurtrstenmark aprotocolforfabricationandonchipcellculturetorecreatepahafflictedpulmonaryarteryonamicrofluidicdevice
AT evasnozik aprotocolforfabricationandonchipcellculturetorecreatepahafflictedpulmonaryarteryonamicrofluidicdevice
AT dipongkorsaha aprotocolforfabricationandonchipcellculturetorecreatepahafflictedpulmonaryarteryonamicrofluidicdevice
AT fakhrulahsan aprotocolforfabricationandonchipcellculturetorecreatepahafflictedpulmonaryarteryonamicrofluidicdevice
AT tanoysarkar protocolforfabricationandonchipcellculturetorecreatepahafflictedpulmonaryarteryonamicrofluidicdevice
AT trieunguyen protocolforfabricationandonchipcellculturetorecreatepahafflictedpulmonaryarteryonamicrofluidicdevice
AT sakibmmoinuddin protocolforfabricationandonchipcellculturetorecreatepahafflictedpulmonaryarteryonamicrofluidicdevice
AT kurtrstenmark protocolforfabricationandonchipcellculturetorecreatepahafflictedpulmonaryarteryonamicrofluidicdevice
AT evasnozik protocolforfabricationandonchipcellculturetorecreatepahafflictedpulmonaryarteryonamicrofluidicdevice
AT dipongkorsaha protocolforfabricationandonchipcellculturetorecreatepahafflictedpulmonaryarteryonamicrofluidicdevice
AT fakhrulahsan protocolforfabricationandonchipcellculturetorecreatepahafflictedpulmonaryarteryonamicrofluidicdevice